Statistical Review and Evaluation

First Page		Document Content
Biology Gynaecological cancer HPV vaccine Cervarix Human papillomavirus Cervical cancer AS04 Immunogenicity Vaccination Papillomavirus Medicine Vaccines		Statistical Review and Evaluation Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 86,78 KB Share Document on Facebook

	INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect DocID: 1rtdm - View Document
	Elvira Ann Marano August 20, October 27, 2010 DocID: 1rpU4 - View Document
	PDF Document DocID: 1rmwK - View Document
	Be Healthy Wellness Benefits Be Healthy– DocID: 1rifu - View Document
	Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat DocID: 1re0N - View Document